Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Impact of body mass index for patients undergoing pancreaticoduodenectomy.

World journal of gastrointestinal pathophysiology

Del Chiaro M, Rangelova E, Ansorge C, Blomberg J, Segersvärd R.
PMID: 23755369
World J Gastrointest Pathophysiol. 2013 May 15;4(2):37-42. doi: 10.4291/wjgp.v4.i2.37.

AIM: To evaluate the impact of body mass index (BMI) on short and long term results after pancreaticoduodenectomies (PD).METHODS: A consecutive series of PDs performed at the Karolinska University Hospital from 2004 till 2010 were retrieved from our prospective...

Cite
Del Chiaro M, Rangelova E, Ansorge C, et al. Impact of body mass index for patients undergoing pancreaticoduodenectomy. World J Gastrointest Pathophysiol. 2013;4(2):37-42doi: 10.4291/wjgp.v4.i2.37.
Del Chiaro, M., Rangelova, E., Ansorge, C., Blomberg, J., & Segersvärd, R. (2013). Impact of body mass index for patients undergoing pancreaticoduodenectomy. World journal of gastrointestinal pathophysiology, 4(2), 37-42. https://doi.org/10.4291/wjgp.v4.i2.37
Del Chiaro, Marco, et al. "Impact of body mass index for patients undergoing pancreaticoduodenectomy." World journal of gastrointestinal pathophysiology vol. 4,2 (2013): 37-42. doi: https://doi.org/10.4291/wjgp.v4.i2.37
Del Chiaro M, Rangelova E, Ansorge C, Blomberg J, Segersvärd R. Impact of body mass index for patients undergoing pancreaticoduodenectomy. World J Gastrointest Pathophysiol. 2013 May 15;4(2):37-42. doi: 10.4291/wjgp.v4.i2.37. PMID: 23755369; PMCID: PMC3676538.
Copy Download .nbib Format: NLM
Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients.

United European gastroenterology journal

Löhr JM, Lönnebro R, Stigliano S, Haas SL, Swahn F, Enochsson L, Noel R, Segersvärd R, Del Chiaro M, Verbeke CS, Arnelo U.
PMID: 26668748
United European Gastroenterol J. 2015 Dec;3(6):551-60. doi: 10.1177/2050640615579806.

BACKGROUND: Diagnosis of pre-malignant and malignant lesions in the bile duct and the pancreas is sometimes cumbersome. This applies in particular to intraductal papillary mucinous neoplasia (IPMN) and bile duct strictures in primary sclerosing cholangitis (PSC).AIMS: To evaluate in...

Cite
Löhr JM, Lönnebro R, Stigliano S, et al. Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients. United European Gastroenterol J. 2015;3(6):551-60doi: 10.1177/2050640615579806.
Löhr, J. M., Lönnebro, R., Stigliano, S., Haas, S. L., Swahn, F., Enochsson, L., Noel, R., Segersvärd, R., Del Chiaro, M., Verbeke, C. S., & Arnelo, U. (2015). Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients. United European gastroenterology journal, 3(6), 551-60. https://doi.org/10.1177/2050640615579806
Löhr, Johannes-Matthias, et al. "Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients." United European gastroenterology journal vol. 3,6 (2015): 551-60. doi: https://doi.org/10.1177/2050640615579806
Löhr JM, Lönnebro R, Stigliano S, Haas SL, Swahn F, Enochsson L, Noel R, Segersvärd R, Del Chiaro M, Verbeke CS, Arnelo U. Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients. United European Gastroenterol J. 2015 Dec;3(6):551-60. doi: 10.1177/2050640615579806. PMID: 26668748; PMCID: PMC4669511.
Copy Download .nbib Format: NLM
A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer.

Journal of immunotherapy (Hagerstown, Md. : 1997)

Omazic B, Ayoglu B, Löhr M, Segersvärd R, Verbeke C, Magalhaes I, Potacova Z, Mattsson J, Terman A, Ghazi S, Albiin N, Kartalis N, Nilsson P, Poiret T, Zhenjiang L, Heuchel R, Schwenk JM, Permert J, Maeurer MJ, Ringden O.
PMID: 28338506
J Immunother. 2017 May;40(4):132-139. doi: 10.1097/CJI.0000000000000164.

We examined the immunologic effects of allogeneic hematopoietic stem cell transplantation (HSCT) in the treatment of pancreatic ductal adenocarcinoma, a deadly disease with a median survival of 24 months for resected tumors and a 5-year survival rate of 6%....

Cite
Omazic B, Ayoglu B, Löhr M, et al. A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer. J Immunother. 2017;40(4):132-139doi: 10.1097/CJI.0000000000000164.
Omazic, B., Ayoglu, B., Löhr, M., Segersvärd, R., Verbeke, C., Magalhaes, I., Potacova, Z., Mattsson, J., Terman, A., Ghazi, S., Albiin, N., Kartalis, N., Nilsson, P., Poiret, T., Zhenjiang, L., Heuchel, R., Schwenk, J. M., Permert, J., Maeurer, M. J., & Ringden, O. (2017). A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer. Journal of immunotherapy (Hagerstown, Md. : 1997), 40(4), 132-139. https://doi.org/10.1097/CJI.0000000000000164
Omazic, Brigitta, et al. "A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer." Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 40,4 (2017): 132-139. doi: https://doi.org/10.1097/CJI.0000000000000164
Omazic B, Ayoglu B, Löhr M, Segersvärd R, Verbeke C, Magalhaes I, Potacova Z, Mattsson J, Terman A, Ghazi S, Albiin N, Kartalis N, Nilsson P, Poiret T, Zhenjiang L, Heuchel R, Schwenk JM, Permert J, Maeurer MJ, Ringden O. A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer. J Immunother. 2017 May;40(4):132-139. doi: 10.1097/CJI.0000000000000164. PMID: 28338506.
Copy Download .nbib Format: NLM
MiR-185-5p regulates the development of myocardial fibrosis.

Journal of molecular and cellular cardiology

Lin R, Rahtu-Korpela L, Szabo Z, Kemppi A, Skarp S, Kiviniemi AM, Lepojärvi ES, Halmetoja E, Kilpiö T, Porvari K, Pakanen L, Tolva J, Paakkanen R, Segersvärd H, Tikkanen I, Laine M, Sinisalo J, Lakkisto P, Huikuri H, Magga J, Junttila J, Kerkelä R.
PMID: 34973276
J Mol Cell Cardiol. 2021 Dec 29; doi: 10.1016/j.yjmcc.2021.12.011. Epub 2021 Dec 29.

BACKGROUND: Cardiac fibrosis stiffens the ventricular wall, predisposes to cardiac arrhythmias and contributes to the development of heart failure. In the present study, our aim was to identify novel miRNAs that regulate the development of cardiac fibrosis and could...

Cite
Lin R, Rahtu-Korpela L, Szabo Z, et al. MiR-185-5p regulates the development of myocardial fibrosis. J Mol Cell Cardiol. 2021;doi: 10.1016/j.yjmcc.2021.12.011.
Lin, R., Rahtu-Korpela, L., Szabo, Z., Kemppi, A., Skarp, S., Kiviniemi, A. M., Lepojärvi, E. S., Halmetoja, E., Kilpiö, T., Porvari, K., Pakanen, L., Tolva, J., Paakkanen, R., Segersvärd, H., Tikkanen, I., Laine, M., Sinisalo, J., Lakkisto, P., Huikuri, H., Magga, J., Junttila, J., & Kerkelä, R. (2021). MiR-185-5p regulates the development of myocardial fibrosis. Journal of molecular and cellular cardiology, . https://doi.org/10.1016/j.yjmcc.2021.12.011
Lin, Ruizhu, et al. "MiR-185-5p regulates the development of myocardial fibrosis." Journal of molecular and cellular cardiology vol. (2021). doi: https://doi.org/10.1016/j.yjmcc.2021.12.011
Lin R, Rahtu-Korpela L, Szabo Z, Kemppi A, Skarp S, Kiviniemi AM, Lepojärvi ES, Halmetoja E, Kilpiö T, Porvari K, Pakanen L, Tolva J, Paakkanen R, Segersvärd H, Tikkanen I, Laine M, Sinisalo J, Lakkisto P, Huikuri H, Magga J, Junttila J, Kerkelä R. MiR-185-5p regulates the development of myocardial fibrosis. J Mol Cell Cardiol. 2021 Dec 29; doi: 10.1016/j.yjmcc.2021.12.011. Epub 2021 Dec 29. PMID: 34973276.
Copy Download .nbib Format: NLM
The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens.

JOP : Journal of the pancreas

Del Chiaro M, Blomberg J, Segersvärd R, Rangelova E, Ansorge C, Verbeke C.
PMID: 25435577
JOP. 2014 Nov 28;15(6):597-9. doi: 10.6092/1590-8577/2856.

CONTEXT: LigaSure™ is considered safe in performing pancreaticoduodenectomy (PD). However, no data are available regarding the possible damage of tissues at the resection margins and the impact thereof on histologic margin assessment.OBJECTIVE: This study compares the degree of histologic...

Cite
Del Chiaro M, Blomberg J, Segersvärd R, et al. The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens. JOP. 2014;15(6):597-9doi: 10.6092/1590-8577/2856.
Del Chiaro, M., Blomberg, J., Segersvärd, R., Rangelova, E., Ansorge, C., & Verbeke, C. (2014). The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens. JOP : Journal of the pancreas, 15(6), 597-9. https://doi.org/10.6092/1590-8577/2856
Del Chiaro, Marco, et al. "The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens." JOP : Journal of the pancreas vol. 15,6 (2014): 597-9. doi: https://doi.org/10.6092/1590-8577/2856
Del Chiaro M, Blomberg J, Segersvärd R, Rangelova E, Ansorge C, Verbeke C. The use of LigaSure™ Does not Affect Histologic Margin Assessment in Pancreatoduodenectomy (PD) specimens. JOP. 2014 Nov 28;15(6):597-9. doi: 10.6092/1590-8577/2856. PMID: 25435577.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries